Zero Candida Technologies (TSXV:ZCT) Other Current Liabilities: C$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:ZCT Zero Candida Technologies Inc TSXV:ZCT
14 GF Score
Price C$0.16
! 1 Warning Sign
View Full Analysis

What is Zero Candida Technologies Other Current Liabilities?

Zero Candida Technologies TSXV:ZCT 14 Other Current Liabilities is C$0.00 Mil as of Dec. 2025. GuruFocus rates TSXV:ZCT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Zero Candida Technologies's other current liabilities for the quarter that ended in Dec. 2025 was C$0.00 Mil.

Zero Candida Technologies's quarterly other current liabilities declined from Jun. 2025 (C$0.00 Mil) to Sep. 2025 (C$0.00 Mil) but then from Sep. 2025 (C$0.00 Mil) to Dec. 2025 (C$0.00 Mil).

Zero Candida Technologies's annual other current liabilities declined from Jul. 2023 (C$0.00 Mil) to Jul. 2024 (C$0.00 Mil) but then stayed the same from Jul. 2024 (C$0.00 Mil) to Dec. 2025 (C$0.00 Mil).


Zero Candida Technologies Other Current Liabilities Related Terms


Zero Candida Technologies Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Zero Candida Technologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies Other Current Liabilities Chart

Zero Candida Technologies Annual Data
Trend Jul23 Jul24 Dec25
Other Current Liabilities
0.00 0.00 0.00

Zero Candida Technologies Quarterly Data
Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:ZCT
14GF Score
Zero Candida Technologies Inc TSXV:ZCT
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zero Candida Technologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of C$0.00 Mil mean?
Zero Candida Technologies (TSXV:ZCT) has a Other Current Liabilities of C$0.00 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Zero Candida Technologies.
Is Zero Candida Technologies' Other Current Liabilities too high?
Zero Candida Technologies' current Other Current Liabilities is C$0.00 Mil. Overall, Zero Candida Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' Other Current Liabilities compare to ABT and SYK?
Zero Candida Technologies' Other Current Liabilities of C$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Zero Candida Technologies. Zero Candida Technologies's current Other Current Liabilities is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current Other Current Liabilities of C$0.00 Mil. The current Other Current Liabilities is C$0.00 Mil. Zero Candida Technologies' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current Other Current Liabilities is C$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zero Candida Technologies Business Description

Address 666 Burrard Street, Suite 500, Vancouver, BC, CAN, V6C 3P6
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
14GF Score

Get the complete analysis for TSXV:ZCT

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price